Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Selective Serotonin Reuptake Inhibitors

Known as: SSRI, SSRIs, Selective Serotonin Reuptake Inhibitor 
Any agent that increases the extracellular level of the neurotransmitter serotonin (5-HT) by inhibiting its reuptake into the presynaptic cell… Expand
National Institutes of Health

Related topics

Related topics

3 relations
Serotonin Reuptake Inhibitor [EPC]response to fluoxetine

Broader (1)

Serotonin Uptake Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis
Summary Background Depression is the single largest contributor to non-fatal health loss worldwide. Second-generation… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Review
2018
Review
2018
Group 1 ITI Consensus Report: The influence of implant length and design and medications on clinical and patient-reported outcomes.
OBJECTIVES The aim of Working Group 1 was to address the influence of different local (implant length, diameter, and design) and… Expand
Review
2018
Review
2018
The contribution of environmental exposure to the etiology of autism spectrum disorder
Autism spectrum disorder (ASD) is a neurodevelopmental condition of heterogeneous etiology. While it is widely recognized that… Expand
Review
2018
Review
2018
QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update.
BACKGROUND Some psychotropic medications have been associated with prolongation of the QT interval and QT prolongation… Expand
Review
2017
Review
2017
The effects of maternal antidepressant use on offspring behaviour and brain development: Implications for risk of neurodevelopmental disorders
Approximately 10% of pregnant women are prescribed antidepressant drugs (ADDs), with selective serotonin reuptake inhibitors… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Review
2017
Review
2017
Long-Term Outcomes of Youth Treated for an Anxiety Disorder: A Critical Review
Pediatric anxiety disorders are common, disabling, and chronic conditions. Efforts over the past two decades have focused on… Expand
Highly Cited
2001
Highly Cited
2001
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
Background It had been suggested that the antidepressant venlafaxine, which inhibits reuptake of both serotonin and (at higher… Expand
Highly Cited
2000
Highly Cited
2000
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
  • I. Anderson
  • Journal of affective disorders
  • 2000
    • Corpus ID: 32353165
BACKGROUND A meta-analysis of the efficacy and tolerability of selective serotonin reuptake inhibitors (SSRIs) against tricyclic… Expand
Review
1994
Review
1994
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
  • J. Hyttel
  • International clinical psychopharmacology
  • 1994
    • Corpus ID: 30166780
Established antidepressants including tricyclic antidepressants (TCAs), tetracyclic antidepressants and monoamine oxidase… Expand
Highly Cited
1993
Highly Cited
1993
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
OBJECTIVE--To examine the evidence for using selective serotonin reuptake inhibitors instead of tricyclic antidepressants in the… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE